SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-091460
Filing Date
2023-08-14
Accepted
2023-08-14 16:52:23
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K grcl-20230630x6k.htm   iXBRL 6-K 115438
2 EXHIBIT 99.1 grcl-20230630xex99d1.htm   iXBRL EX-99.1 1118907
3 EXHIBIT 99.2 grcl-20230630xex99d2.htm EX-99.2 20423
  Complete submission text file 0001104659-23-091460.txt   7271342

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA grcl-20230630.xsd EX-101.SCH 66668
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grcl-20230630_cal.xml EX-101.CAL 61466
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grcl-20230630_def.xml EX-101.DEF 225017
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE grcl-20230630_lab.xml EX-101.LAB 499091
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grcl-20230630_pre.xml EX-101.PRE 402551
68 EXTRACTED XBRL INSTANCE DOCUMENT grcl-20230630x6k_htm.xml XML 1443411
Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Filer) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39838 | Film No.: 231171557
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences